DNA-methylation subgroups carry no prognostic significance in ATRT-SHH patients in clinical trial cohorts.

Quynh T TranSanthosh A UpadhyayaCatherine A BillupsArzu Onar-ThomasMd Zahangir AlomSteven S CareyGiles W RobinsonDavid W EllisonAmar GajjarBrent A Orr

Published in: Acta neuropathologica (2023)

Keyphrases

dna methylation
clinical trial
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
gene expression
peritoneal dialysis
genome wide
open label
study protocol
double blind
copy number